Cancer antigen 15/3: possible diagnostic use in veterinary clinical oncology. Preliminary study
Authors:
- 1 May 2010
- journal article
- abstracts
- Published by Springer Nature in Veterinary Research Communications
- Vol. 34 (S1) , 103-106
Abstract
The cancer antigen 15/3 is a mucin that is associated with the cell membrane, encoded by the MUC1 gene, and recognized by the monoclonal-clone DF3 antibody. The latter antigen was discovered to be specific for both the identification of human mammary neoplasia and during patient follow-up evaluations. The aim of this study is to report and compare the results of the application of direct chemiluminescence in canine blood sera and the kit utilized in human medicine for the determination of Ca 15/3 to verify the diagnostic efficiency of the kit in cases presenting mammary tumors. Specifically, CA 15/3 has proven to be measurable in all samples assayed to distinguish clinically healthy subjects from those with mammary neoplasia.Keywords
This publication has 9 references indexed in Scilit:
- CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancerBMC Cancer, 2006
- Total Serum Alkaline Phosphatase Activity in Dogs with Mammary Neoplasms: a Prospective Study on 79 Natural CasesJournal of Veterinary Medicine Series A, 2003
- Tumors of the Mammary Gland2002
- Factors influencing the incidence and prognosis of canine mammary tumoursJournal of Small Animal Practice, 2000
- Elevated Circulating CA 15.3 Levels in a Subset of Systemic Sclerosis With Severe Lung InvolvementArchives of Dermatology, 1998
- The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigenCancer, 1991
- Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseasesBreast Cancer Research and Treatment, 1989
- Ca 15.3 as a Tumour Marker in Breast CancerThe International Journal of Biological Markers, 1987
- Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.Journal of Clinical Oncology, 1986